Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine

Peptides

Volumn 32, Issue 2, 2011, Pages 293-299

  Wang, Chang Lin ^a,b   Guo, Chao ^a   Wang, Yi Qing ^a   Zhou, Ying ^a   Li, Qian ^a   Ni, Jing Man ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Opioid receptor; Antinociception; BBB; CPPs; Endomorphin 1 analogs; Oligoarginine

Indexed keywords

ARGININE DERIVATIVE; ENDOMORPHIN 1; NALOXONE; OPIATE RECEPTOR;

ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BLOOD BRAIN BARRIER; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SYNTHESIS;

ANALGESICS, OPIOID; ANIMALS; ARGININE; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GUINEA PIGS; ILEUM; MALE; MICE; MICE, INBRED STRAINS; MUSCLE CONTRACTION; NALOXONE; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; VAS DEFERENS;

EID: 78751645959     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.10.024     Document Type: Article

References (43)

1. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
2. B.J. Calnan, B. Tidor, S. Biancalana, D. Hudson, and A.D. Frankel Arginine-mediated RNA recognition: the arginine fork Science 252 1991 1167 1171
3. G. Cao, W. Pei, H. Ge, Q. Liang, Y. Luo, and F.R. Sharp In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis J Neurosci 22 2002 5423 5431
4. M. Chang, Y.L. Peng, S.L. Dong, R.W. Han, W. Li, and D.J. Yang Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor Regul Pept 130 2005 116 122
5. 50) of an enzymatic reaction Biochem Pharmacol 22 1973 3099 3108
6. M.A. Czapla, D. Gozal, O.A. Alea, R.C. Beckerman, and J.E. Zadina Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine Am J Respir Crit Care Med 162 2000 994 999
7. A.G. de Boer, and P.J. Gaillard Strategies to improve drug delivery across the blood-brain barrier Clin Pharmacokinet 46 2007 553 576
8. M. Dhanasekaran, and R. Polt New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood-brain barrier Curr Drug Deliv 2 2005 59 73
9. R.D. Egleton, S.A. Mitchell, J.D. Huber, M.M. Palian, R. Polt, and T.P. Davis Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation J Pharmacol Exp Ther 299 2001 967 972
10. N.O. Elmagbari, R.D. Egleton, M.M. Palian, J.J. Lowery, W.R. Schmid, and P. Davis Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides J Pharmacol Exp Ther 311 2004 290 297
11. M. Furuhata, H. Kawakami, K. Toma, Y. Hattori, and Y. Maitani Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length Bioconjug Chem 17 2006 935 942
12. S. Futaki Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms Biopolymers 84 2006 241 249
13. C.L. Gentry, R.D. Egleton, T. Gillespie, T.J. Abbruscato, H.B. Bechowski, and V.J. Hruby The effect of halogenation on blood-brain barrier permeability of a novel peptide drug Peptides 20 1999 1229 1238
14. T.J. Haley, and W.G. Mccormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br J Pharmacol Chemother 12 1957 12 15
15. V.S. Hau, J.D. Huber, C.R. Campos, A.W. Lipkowski, A. Misicka, and T.P. Davis Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II J Pharm Sci 91 2002 2140 2149
16. P. Jolliet-Riant, and J.P. Tillement Drug transfer across the blood-brain barrier and improvement of brain delivery Fundam Clin Pharmacol 13 1999 16 26
17. R. Kruszynski, J. Fichna, J.C. do-Rego, T. Janecki, P. Kosson, and W. Pakulska Synthesis and biological activity of N-methylated analogs of endomorphin-2 Bioorg Med Chem 13 2005 6713 6717 (Pubitemid 41571215)
18. H.M. Liu, X.F. Liu, J.L. Yao, C.L. Wang, Y. Yu, and R. Wang Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1 J Pharmacol Exp Ther 319 2006 308 316
19. L. Negri, R. Lattanzi, F. Tabacco, B. Scolaro, and R. Rocchi Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration Br J Pharmacol 124 1998 1516 1522
20. L. Negri, R. Lattanzi, F. Tabacco, L. Orr, C. Severini, and B. Scolaro Dermorphin and deltorphin glycosylated analogues: synthesis and antinociceptive activity after systemic administration J Med Chem 42 1999 400 404
21. W.M. Pardridge New approaches to drug delivery through the blood-brain barrier Trends Biotechnol 12 1994 239 245
22. L.N. Patel, J.L. Zaro, and W.C. Shen Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives Pharm Res 24 2007 1977 1992
23. R. Perlikowska, J.C. do-Rego, A. Cravezic, J. Fichna, A. Wyrebska, and G. Toth Synthesis and biological evaluation of cyclic endomorphin-2 analogs Peptides 31 2010 339 345
24. W. Pham, B.Q. Zhao, E.H. Lo, Z. Medarova, B. Rosen, and A. Moore Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging Neuroimage 28 2005 287 292
25. R. Polt, F. Porreca, L.Z. Szab, E.J. Bilsky, P. Davis, and T.J. Abbruscato Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier Proc Natl Acad Sci USA 9 1994 7114 7118
26. R. Przewłocki, D. Labuz, J. Mika, B. Przewłocka, C. Tomboly, and G. Toth Pain inhibition by endomorphins Ann NY Acad Sci 897 1999 154 164
27. C. Rousselle, P. Clair, J.M. Lefauconnier, M. Kaczorek, J.M. Scherrmann, and J. Temsamani New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy Mol Pharmacol 57 2000 679 686
28. C. Rousselle, P. Clair, M. Smirnova, Y. Kolesnikov, G.W. Pasternak, and S. Gac-Breton Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy J Pharmacol Exp Ther 306 2003 371 376
29. C. Rousselle, P. Clair, J. Temsamani, and J.M. Scherrmann Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy J Drug Target 10 2002 309 315
30. C. Rousselle, M. Smirnova, P. Clair, J.M. Lefauconnier, A. Chavanieu, and B. Calas Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity J Pharmacol Exp Ther 296 2001 124 131
31. J.E. Shook, J.T. Pelton, W.S. Wire, L.D. Hirning, V.J. Hruby, and T.F. Burks Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro J Pharmacol Exp Ther 240 1987 772 777
32. J. Simon, S. Benyhe, K. Abutidze, A. Borsodi, M. Szücs, and G. Tóth Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS J Neurochem 46 1986 695 701
33. S. Spampinato, A.R. Qasem, M. Calienni, G. Murari, L. Gentilucci, and A. Tolomelli Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline Eur J Pharmacol 469 2003 89 95
34. J. Temsamani, C. Rousselle, A.R. Rees, and J.M. Scherrmann Vector-mediated drug delivery to the brain Expert Opin Biol Ther 1 2001 773 782
35. J. Temsamani, J.M. Scherrmann, A.R. Rees, and M. Kaczorek Brain drug delivery technologies: novel approaches for transporting therapeutics Pharm Sci Technol Today 3 2000 155 162
36. J. Temsamani, and P. Vidal The use of cell-penetrating peptides for drug delivery Drug Discov Today 9 2004 1012 1019
37. C.L. Wang, J.L. Yao, Y. Yu, X. Shao, Y. Cui, and H.M. Liu Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling Bioorg Med Chem 16 2008 6415 6422
38. A.M. Wilson, R.D. Soignier, J.E. Zadina, A.J. Kastin, W.L. Nores, and R.D. Olson Dissociation of analgesic and rewarding effects of endomorphin-1 in rats Peptides 21 2002 1871 1874
39. K.A. Witt, T.J. Gillespie, J.D. Huber, R.D. Egleton, and T.P. Davis Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability Peptides 22 2001 2329 2343
40. S.R. Yang, S.B. Kim, C.O. Joe, and J.D. Kim Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation J Biomed Mater Res A 86 2008 137 148
41. Y. Yu, X. Shao, Y. Cui, H.M. Liu, C.L. Wang, and Y.Z. Fan Structure-activity study on the spatial arrangement of the third aromatic ring of endomorphins 1 and 2 using an atypical constrained C terminus ChemMedChem 2 2007 309 317
42. J.E. Zadina, L. Hackler, L.J. Ge, and A.J. Kastin A potent and selective endogenous agonist for the mu-opiate receptor Nature 386 1997 499 502
43. J.L. Zaro, and W.C. Shen Quantitative comparison of membrane transduction and endocytosis of oligopeptides Biochem Biophys Res Commun 307 2003 241 247